Detailed Notes on DO-264
Detailed Notes on DO-264
Blog Article
quinupristin/dalfopristin will raise the degree or outcome of quinine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
quinupristin/dalfopristin will raise the level or impact of sunitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
quinupristin/dalfopristin will increase the stage or result of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Keep track of clients by now on buprenorphine subdermal implant who demand recently-initiated therapy with CYP3A4 inhibitors for symptoms and signs and symptoms of overmedication.
quinupristin/dalfopristin will enhance the stage or influence of vinblastine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
Major - Use Alternative (one)quinupristin/dalfopristin will raise the level or influence of pink yeast rice by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
Monitor for signs or symptoms of hypotension and edema when amlodipine is coadministered with CYP3A inhibitors to determine the necessity for dose adjustment.
quinupristin/dalfopristin will increase the amount or impact of diazepam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
quinupristin/dalfopristin will boost the level or effect of lopinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
quinupristin/dalfopristin will raise the degree or result of ivosidenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
In selecting to make use of a medicine, the hazards of getting the medicine has to be weighed from The nice it will do. This can be a decision you and your medical doctor will make. For this medicine, the following ought to be regarded:
quinupristin/dalfopristin will reduce the level or outcome of thiamine by altering intestinal flora. Applies only to oral form of equally brokers. Minimal/Importance Not known.
quinupristin/dalfopristin will increase the stage or result of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
quinupristin/dalfopristin will minimize the extent or effect of bazedoxifene/conjugated estrogens by altering intestinal Lipoteichoic acid flora. Applies only to oral kinds of hormone. Small threat of contraceptive failure. Use Caution/Watch.
quinupristin/dalfopristin will increase the stage or impact of clarithromycin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.